Company profile: Spago Nanomedical
1.1 - Company Overview
Company description
- Provider of nanomedicine R&D, offering SpagoPix (SN132D), a gadolinium-free MRI contrast agent for precise imaging of solid tumors and other severe diseases, and Tumorad, a nanoparticle-based radionuclide therapy project for treatment of solid soft tissue tumors.
Products and services
- Nanomedicine R&D: Nanomedicine-focused research and development performed by the company, executing investigations and R&D activities within nanoscale medical science to progress nanomedicine
- SpagoPix (SN132D): A gadolinium-free MRI contrast agent engineered to enhance signal for precise imaging of solid tumors and other severe diseases in magnetic resonance scans
- Tumorad: A nanoparticle-based radionuclide therapy project employing particles loaded with radioactive isotopes to target and treat solid soft tissue tumors
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Spago Nanomedical
Avadel Pharmaceuticals
HQ: Ireland
Website
- Description: Provider of specialty pharmaceutical products developed via proprietary drug delivery technology and in-licensing/acquisitions to create safe, effective, easy-to-take formulations; offers LUMRYZ, a central nervous system depressant for treating cataplexy or excessive daytime sleepiness in adults with narcolepsy, available through a restricted program.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Avadel Pharmaceuticals company profile →
Genia Technologies
HQ: United States
Website
- Description: Provider of biotechnology leveraging biological nanopores for structure-based sequencing of single DNA molecules, aiming to reduce the price of genome sequencing toward the $100 genome and bring sequencing out of the lab into everyday use.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genia Technologies company profile →
Peak Nano
HQ: United States
Website
- Description: Provider of nanotechnology products: GRIN lenses offering higher electro-optical performance in visible to near-infrared at lower size, weight and volume; Peak HawkSight Optics using LGRIN for night vision, fire control and unmanned aircraft systems; NanoPlex capacitor films for power grids and fusion energy; and NanoPlex films for aerospace protection.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Peak Nano company profile →
Izon Science
HQ: New Zealand
Website
- Description: Provider of nano-biological separation and characterization tools for universities and research institutions, enabling isolation and measurement of biological and synthetic nanoparticles, including extracellular vesicles, nano plastics, viruses, and virus-like particles. Products include the qEV size exclusion chromatography platform, TRPS for size, concentration and zeta potential, Exoid, and the Automatic Fraction Collector.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Izon Science company profile →
Integrated Plasmonics
HQ: United States
Website
- Description: Provider of CMOS devices with integrated plasmonic surface-sensing to spectrographically examine biochemical samples without the need for markers or bulky external equipment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Integrated Plasmonics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Spago Nanomedical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Spago Nanomedical
2.2 - Growth funds investing in similar companies to Spago Nanomedical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Spago Nanomedical
4.2 - Public trading comparable groups for Spago Nanomedical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →